<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Chaitman, Bernard R.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Findings from BARI 2D</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-25</style></pages><abstract><style  face="normal" font="default" size="100%">For patients with type 2 diabetes and stable coronary artery disease (CAD), intensive medical therapy provides similar protection against myocardial infarctionand cardiac death compared with percutaneous coronary intervention but is not as effective as coronary artery bypass grafting among patients with more extensive CAD, according to new findings from the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D; NCT00006305] trial.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>